237 related articles for article (PubMed ID: 27881717)
1. Localization of 1-deoxysphingolipids to mitochondria induces mitochondrial dysfunction.
Alecu I; Tedeschi A; Behler N; Wunderling K; Lamberz C; Lauterbach MA; Gaebler A; Ernst D; Van Veldhoven PP; Al-Amoudi A; Latz E; Othman A; Kuerschner L; Hornemann T; Bradke F; Thiele C; Penno A
J Lipid Res; 2017 Jan; 58(1):42-59. PubMed ID: 27881717
[TBL] [Abstract][Full Text] [Related]
2. 1-Deoxysphingolipids cause autophagosome and lysosome accumulation and trigger NLRP3 inflammasome activation.
Lauterbach MA; Saavedra V; Mangan MSJ; Penno A; Thiele C; Latz E; Kuerschner L
Autophagy; 2021 Aug; 17(8):1947-1961. PubMed ID: 32835606
[TBL] [Abstract][Full Text] [Related]
3. Fenofibrate lowers atypical sphingolipids in plasma of dyslipidemic patients: A novel approach for treating diabetic neuropathy?
Othman A; Benghozi R; Alecu I; Wei Y; Niesor E; von Eckardstein A; Hornemann T
J Clin Lipidol; 2015; 9(4):568-75. PubMed ID: 26228675
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic 1-deoxysphingolipids are metabolized by a cytochrome P450-dependent pathway.
Alecu I; Othman A; Penno A; Saied EM; Arenz C; von Eckardstein A; Hornemann T
J Lipid Res; 2017 Jan; 58(1):60-71. PubMed ID: 27872144
[TBL] [Abstract][Full Text] [Related]
5. Elucidating the chemical structure of native 1-deoxysphingosine.
Steiner R; Saied EM; Othman A; Arenz C; Maccarone AT; Poad BL; Blanksby SJ; von Eckardstein A; Hornemann T
J Lipid Res; 2016 Jul; 57(7):1194-203. PubMed ID: 27165858
[TBL] [Abstract][Full Text] [Related]
6. Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats.
Othman A; Bianchi R; Alecu I; Wei Y; Porretta-Serapiglia C; Lombardi R; Chiorazzi A; Meregalli C; Oggioni N; Cavaletti G; Lauria G; von Eckardstein A; Hornemann T
Diabetes; 2015 Mar; 64(3):1035-45. PubMed ID: 25277395
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of HSAN1- and T2DM-associated 1-deoxy-sphingolipids inhibits the migration of fibroblasts.
Karsai G; Steiner R; Kaech A; Lone MA; von Eckardstein A; Hornemann T
J Lipid Res; 2021; 62():100122. PubMed ID: 34563520
[TBL] [Abstract][Full Text] [Related]
8. Hereditary sensory neuropathy type 1-associated deoxysphingolipids cause neurotoxicity, acute calcium handling abnormalities and mitochondrial dysfunction in vitro.
Wilson ER; Kugathasan U; Abramov AY; Clark AJ; Bennett DLH; Reilly MM; Greensmith L; Kalmar B
Neurobiol Dis; 2018 Sep; 117():1-14. PubMed ID: 29778900
[TBL] [Abstract][Full Text] [Related]
9. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
[TBL] [Abstract][Full Text] [Related]
10. Hereditary sensory and autonomic neuropathy type 1 (HSANI) caused by a novel mutation in SPTLC2.
Murphy SM; Ernst D; Wei Y; Laurà M; Liu YT; Polke J; Blake J; Winer J; Houlden H; Hornemann T; Reilly MM
Neurology; 2013 Jun; 80(23):2106-11. PubMed ID: 23658386
[TBL] [Abstract][Full Text] [Related]
11. A Novel Variant (Asn177Asp) in SPTLC2 Causing Hereditary Sensory Autonomic Neuropathy Type 1C.
Suriyanarayanan S; Othman A; Dräger B; Schirmacher A; Young P; Mulahasanovic L; Hörtnagel K; Biskup S; von Eckardstein A; Hornemann T; Lone MA
Neuromolecular Med; 2019 Jun; 21(2):182-191. PubMed ID: 30955194
[TBL] [Abstract][Full Text] [Related]
12. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids.
Penno A; Reilly MM; Houlden H; Laurá M; Rentsch K; Niederkofler V; Stoeckli ET; Nicholson G; Eichler F; Brown RH; von Eckardstein A; Hornemann T
J Biol Chem; 2010 Apr; 285(15):11178-87. PubMed ID: 20097765
[TBL] [Abstract][Full Text] [Related]
13. Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy.
Gantner ML; Eade K; Wallace M; Handzlik MK; Fallon R; Trombley J; Bonelli R; Giles S; Harkins-Perry S; Heeren TFC; Sauer L; Ideguchi Y; Baldini M; Scheppke L; Dorrell MI; Kitano M; Hart BJ; Cai C; Nagasaki T; Badur MG; Okada M; Woods SM; Egan C; Gillies M; Guymer R; Eichler F; Bahlo M; Fruttiger M; Allikmets R; Bernstein PS; Metallo CM; Friedlander M
N Engl J Med; 2019 Oct; 381(15):1422-1433. PubMed ID: 31509666
[TBL] [Abstract][Full Text] [Related]
14. Divergent amino acid and sphingolipid metabolism in patients with inherited neuro-retinal disease.
Green CR; Bonelli R; Ansell BRE; Tzaridis S; Handzlik MK; McGregor GH; Hart B; Trombley J; Reilly MM; Bernstein PS; Egan C; Fruttiger M; Wallace M; Bahlo M; Friedlander M; Metallo CM; Gantner ML
Mol Metab; 2023 Jun; 72():101716. PubMed ID: 36997154
[TBL] [Abstract][Full Text] [Related]
15. Deoxysphingoid bases as plasma markers in diabetes mellitus.
Bertea M; Rütti MF; Othman A; Marti-Jaun J; Hersberger M; von Eckardstein A; Hornemann T
Lipids Health Dis; 2010 Aug; 9():84. PubMed ID: 20712864
[TBL] [Abstract][Full Text] [Related]
16. Functional and Molecular Characterization of New
Rochat J; Blavier A; Ruet S; Vasseur S; Puma A; Desnous B; Chan V; Delmont E; Attarian S; Juntas Morales R; Quadrio I; Vidoni L; Bonello-Palot N; Cheillan D
Genes (Basel); 2024 May; 15(6):. PubMed ID: 38927628
[TBL] [Abstract][Full Text] [Related]
17. Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus.
Mwinyi J; Boström A; Fehrer I; Othman A; Waeber G; Marti-Soler H; Vollenweider P; Marques-Vidal P; Schiöth HB; von Eckardstein A; Hornemann T
PLoS One; 2017; 12(5):e0175776. PubMed ID: 28472035
[TBL] [Abstract][Full Text] [Related]
18. A Model of Hereditary Sensory and Autonomic Neuropathy Type 1 Reveals a Role of Glycosphingolipids in Neuronal Polarity.
Cui M; Ying R; Jiang X; Li G; Zhang X; Zheng J; Tam KY; Liang B; Shi A; Göbel V; Zhang H
J Neurosci; 2019 Jul; 39(29):5816-5834. PubMed ID: 31138658
[TBL] [Abstract][Full Text] [Related]
19. 1-Deoxysphingolipids.
Lone MA; Santos T; Alecu I; Silva LC; Hornemann T
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Apr; 1864(4):512-521. PubMed ID: 30625374
[TBL] [Abstract][Full Text] [Related]
20. Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1.
Garofalo K; Penno A; Schmidt BP; Lee HJ; Frosch MP; von Eckardstein A; Brown RH; Hornemann T; Eichler FS
J Clin Invest; 2011 Dec; 121(12):4735-45. PubMed ID: 22045570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
